Actinium Pharmaceuticals, Inc. (ATNM)

Actinium Pharmaceuticals Revenue

Actinium Pharmaceuticals had revenue of $90.00K in the twelve months ending March 31, 2026. In the year 2025, Actinium Pharmaceuticals had annual revenue of $90.00K.

• Revenue (ttm): $90.00K
• Revenue Growth: n/a
• P/S Ratio: 377.58
• Revenue / Employee: $3,600
• Employees: 25
• Market Cap: 33.67M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	90.00K	-	-
Dec 31, 2024	-	-	-
Dec 31, 2023	81.00K	-949.00K	-92.14%
Dec 31, 2022	1.03M	-114.00K	-9.97%
Dec 31, 2021	1.14M	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 1, 2026

Data Sources Report a data error